Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HCRT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | HCRT |
| Key Genes/Proteins | OX1, OX2, HCRTR1, HCRTR2 |
| Related Diseases | Narcolepsy Type 1, Alcohol Use Disorder, Alcohol Drinking, Arousal Dysfunction, Hypertension |
Knowledge base pages for this entity
graph TD
HCRT["HCRT"]
style HCRT fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
HCRT -->|"activates"| Als["Als"]
HCRT -->|"activates"| Ms["Ms"]
HCRT -->|"target for"| Cardiovascular["Cardiovascular"]
HCRT -->|"expressed in"| Aging["Aging"]
HCRT -->|"implicated in"| neurodegeneration["neurodegeneration"]
HCRT -->|"interacts"| HCRTR2([HCRTR2])
HCRT -->|"interacts"| HCRTR1([HCRTR1])
HCRT -->|"causes"| narcolepsy["narcolepsy"]
h_6b84d8e2["h-6b84d8e2"] -->|"targets"| HCRT
HCRTR2 -->|"regulates"| HCRT
KCNQ2([KCNQ2]) -->|"regulates"| HCRT
NEURON([NEURON]) -->|"expressed in"| HCRT
AGING([AGING]) -->|"expressed in"| HCRT
Neuropeptide_and_Endocrine_Sig["Neuropeptide and Endocrine Signaling in CBS/PSP"] -->|"references"| HCRT| Target | Relation | Type | Str |
|---|---|---|---|
| OX1 | activates | protein | 0.95 |
| OX2 | activates | protein | 0.95 |
| Narcolepsy Type 1 | implicated_in | disease | 0.95 |
| Crf Neurons | interacts_with | cell_type | 0.95 |
| HCRTR1 | co_mentioned_with | gene | 0.90 |
| HCRTR2 | co_mentioned_with | gene | 0.90 |
| Alcohol Use Disorder | implicated_in | disease | 0.90 |
| Alcohol Drinking | regulates | phenotype | 0.90 |
| arousal regulation | mediates | process | 0.90 |
| arousal state control | mediates | process | 0.85 |
| Arousal Dysfunction | regulates | phenotype | 0.85 |
| thalamus | expressed_in | brain_region | 0.80 |
| Blood Pressure Regulation | regulates | process | 0.80 |
| Hypertension | associated_with | disease | 0.80 |
| Sleep Regulation | involved_in | process | 0.80 |
| sleep disorders | associated_with | disease | 0.70 |
| neurons | associated_with | cell_type | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Sleep Disorder | regulates | disease | 0.65 |
| Sleep Disorder | causes | disease | 0.65 |
| Addiction | associated_with | disease | 0.65 |
| Addiction | activates | disease | 0.65 |
| Addiction | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | regulates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Obesity | causes | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Autoimmune | causes | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Anxiety | inhibits | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Lewy Body | expressed_in | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-6b84d8e2 | targets_gene | hypothesis | 0.90 |
| h-6b84d8e2 | targets | hypothesis | 0.80 |
| HCRTR2 | regulates | gene | 0.60 |
| KCNQ2 | regulates | gene | 0.60 |
| QRFP | biomarker_for | gene | 0.60 |
| TAU | expressed_in | gene | 0.60 |
| HCRTR2 | expressed_in | gene | 0.60 |
| ACE | associated_with | gene | 0.60 |
| HCRTR2 | associated_with | gene | 0.60 |
| HCRTR1 | regulates | gene | 0.60 |
| CRH | causes | gene | 0.60 |
| OXR1 | inhibits | gene | 0.60 |
| HCRTR1 | activates | gene | 0.60 |
| HCRTR1 | associated_with | gene | 0.60 |
| ACE | interacts_with | gene | 0.60 |
| NEURON | expressed_in | gene | 0.60 |
| AGING | expressed_in | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| DEMENTIA | regulates | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| ANXIETY | therapeutic_target | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| NEURODEGENERATION | causes | gene | 0.60 |
| DMSO | inhibits | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| ANXIETY | inhibits | gene | 0.60 |
| AND | causes | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| AND | stabilizes | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| SLEEP-WAKE CYCLE | associated_with | gene | 0.60 |
| NEURON | causes | gene | 0.60 |
| HCRTR2 | binds_to | protein | 0.60 |
| C1Q | activates | gene | 0.55 |
| HCRTR2 | interacts_with | gene | 0.50 |
| narcolepsy | causes | disease | 0.50 |
| narcolepsy | associated_with | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Hypocretin-Neurogenesis Coupling Therapy | 0.452 | neurodegeneration | Sleep disruption as cause and consequenc |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.557
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| EMI1 switches from being a substrate to an inhibitor of APC/C(CDH1) to start the [PMID:29875408] | Cappell SD, Mark KG, Garbett D, Pack LR, | Nature | 2018 | 1 |
| Metabolic fate of glucose and candidate signaling and excess-fuel detoxification [PMID:28280244] | Mugabo Y, Zhao S, Lamontagne J, Al-Mass | J Biol Chem | 2017 | 1 |
| Sleep drives metabolite clearance from the adult brain. [PMID:24136970] | Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th | Science | 2013 | 1 |
| Exposure to 1800 MHz radiofrequency radiation induces oxidative damage to mitoch [PMID:19879861] | Xu S, Zhou Z, Zhang L, Yu Z, Zhang W, Wa | Brain Res | 2010 | 1 |
| Nucleotide signaling and cutaneous mechanisms of pain transduction. [PMID:19171165] | Dussor G, Koerber HR, Oaklander AL, Rice | Brain Res Rev | 2009 | 1 |
| Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces [PMID:38123729] | Bandarabadi M, Li S, Aeschlimann L, Colo | Molecular psychiatry | 2024 | 0 |
| Fresh versus frozen embryo transfers in assisted reproduction. [PMID:33539543] | ["Zaat T", "Zagers M", "Mol F", "Goddijn | The Cochrane database of syste | 2021 | 0 |
| Reciprocal associations between depression, anxiety and work-related injury. [PMID:31685530] | ["Gerasimaviciute V", "B\u00fcltmann U", | Injury prevention : journal of | 2020 | 0 |
| Diabetic neuropathy. [PMID:31197153] | ["Feldman E", "Callaghan B", "Pop-Busui | Nature reviews. Disease primer | 2019 | 0 |
| Views and experiences with regard to antibiotic use of hospitalized patients in [PMID:29777924] | ["Zanichelli V", "Monnier A", "Tebano G" | Clinical microbiology and infe | 2019 | 0 |
| [ [PMID:30543234] | ["Isaac-Oliv\u00e9 K", "Ocampo-Garc\u00e | Nanoscale | 2019 | 0 |
| Spatial and temporal heterogeneity of mouse and human microglia at single-cell r [PMID:30760929] | ["Masuda T", "Sankowski R", "Staszewski | Nature | 2019 | 0 |
| Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease. [PMID:29425372] | Olsson M, Ärlig J, Hedner J, Blennow K, | Sleep | 2018 | 0 |
| Human hippocampal neurogenesis drops sharply in children to undetectable levels [PMID:29513649] | ["Sorrells S", "Paredes M", "Cebrian-Sil | Nature | 2018 | 0 |
| A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Mod [PMID:29805100] | Borniger JC, Walker Ii WH, Surbhi, Emmer | Cell metabolism | 2018 | 0 |
| Environmental Surveillance of Norovirus Genogroups I and II for Sensitive Detect [PMID:28213546] | ["Kazama S", "Miura T", "Masago Y", "Kon | Applied and environmental micr | 2017 | 0 |
| Probing the excitonic landscape of the Chlorobaculum tepidum Fenna-Matthews-Olso [PMID:28159567] | ["Saer R", "Stadnytskyi V", "Magdaong N" | Biochimica et biophysica acta. | 2017 | 0 |
| Atmospheric pressure mass spectrometric imaging of live hippocampal tissue slice [PMID:29235455] | ["Kim J", "Seo E", "Kim H", "Park J", "L | Nature communications | 2017 | 0 |
| Challenges in the development of therapeutics for narcolepsy. [PMID:26721620] | Black SW, Yamanaka A, Kilduff TS | Progress in neurobiology | 2017 | 0 |
| Animal model of Sar1b deficiency presents lipid absorption deficits similar to A [PMID:25559265] | ["Levic D", "Minkel J", "Wang W", "Rybsk | Journal of molecular medicine | 2015 | 0 |